Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
This fourth edition of the European Cardiovascular Disease Statistics is published jointly by the European Society of Cardiology, the European Heart Network and the British Heart Foundation Health Promotion Research Group, Department of Public Health, University of Oxford. The report is part of the European Heart Health Strategy II (EuroHeart II) project and benefits from co-funding from the European Union in the Framework of the health programme.
Each year cardiovascular disease (CVD) causes over 4 million deaths in Europe and 1.9 million deaths in the European Union (EU).
CVD causes 47% of all deaths in Europe and 40% in the EU.
CVD is the main cause of death in women in all countries of Europe and is the main cause of death in men in all but 6 countries.
Death rates from CHD are generally higher in Central and Eastern Europe than in Northern, Southern and Western Europe.
Death rates from stroke are many times higher in Central and Eastern Europe than in Northern, Southern and Western Europe.
CVD mortality is now falling in most European countries, including Central and Eastern European countries which saw large increases until the beginning of the 21st century.
Smoking remains a major public health issue in Europe. Although smoking has declined in many European countries the rate of decline is now slow and rates remain stable or are increasing in some countries, particularly among women.
Women are now smoking nearly as much as men in many European countries and girls often smoke more than boys.
Fruit and vegetable consumption has increased overall across Europe in recent decades, while overall fat consumption has remained stable.
Few adults in European countries participate in adequate levels of physical activity, with inactivity more common among women than men.
Levels of obesity are high across Europe in both adults and children, although rates vary substantially between countries.
The prevalence of diabetes in Europe is high and has increased rapidly over the last ten years, increasing by more than 50% in many countries.
Overall CVD is estimated to cost the EU economy almost €196 billion a year.
Of the total cost of CVD in the EU, around 54% is due to health care costs, 24% due to productivity losses and 22% due to the informal care of people with CVD.
Read the press release here.Please click here to access the visuals.
© 2017 European Society of Cardiology. All rights reserved